ALB and neoplasm: To date, the clinical approvals for tumor therapy are organic materials, including liposomes (pegylated or non-pegylated) and albumin, while inorganic materials are used for tracking and molecular imaging functions, and only superparamagnetic iron oxide (SPIO) nanoparticles are approved in clinical (1).